CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Chongqing Jiheng Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Chongqing Jiheng Pharmaceutical Co Ltd
No.199 Shengxing Street
Sansheng Town, Beibei District
Phone: +86 2368239069p:+86 2368239069 CHONGQING, CHO  400000  China Ticker: 002742002742
Business Summary
Chongqing Jiheng Pharmaceutical Co Ltd, formerly Chongqing Sansheng Industrial Co Ltd is a China-based company primarily engaged in building materials and chemical, and pharmaceutical manufacturing businesses. The Company operates two main businesses. The building materials and chemical business is primarily engaged in the production and sales of ready-mixed concrete, water-reducing agents, expanding agents and sulfuric acid. The pharmaceutical manufacturing business is primarily engaged in the production and sales of pharmaceutical intermediates such as procaine hydrochloride and cefoxitin intermediates, active pharmaceutical ingredients (APIs) such as acetaminophen and clopidogrel hydrochloride, and pharmaceutical preparations such as compound acetaminophen and diphenhydramine tablets, and clopidogrel hydrochloride tablets. The Company conducts its businesses in the domestic market and overseas markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
3273 Ready-mixed concrete
3241 Cement, hydraulic
2819 Industrial inorganic chemicals, not elsewhere classified
3272 Concrete products, except block and brick
2899 Chemicals and chemical preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board YingjianSong 50 12/29/2025 12/29/2025
Vice Chairman of the Board WeiweiDuan 36 12/29/2025 12/29/2025
Chief Financial Officer XuemeiLiu 45 12/29/2025 12/29/2025
9 additional Officers and Directors records available in full report.

Business Names
Business Name
002742
Chongqing Chunrui Pharmaceutical and Chemical Co. Ltd.

General Information
Number of Employees: 979 (As of 12/31/2025)
Outstanding Shares: 684,102,041 (As of 3/31/2026)
Shareholders: 11,713
Stock Exchange: SHE
Fax Number: +86 2368340020


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, June 14, 2026